Medtronic, yesterday, announced it has received Breakthrough Device Designation from the US FDA for its Personalised Closed Loop (PCL) insulin pump system - currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, personalised and adapts to the user; very much similar to AAPS. The system will also... Continue Reading →